The breast cancer epidemic: 10 facts

References

• American Cancer Society. 2012. What are the risk factors for breast cancer? http://www.cancer.org/cancer/breastcancer/detailedguide/breast-cancer-risk-factors. Rev. December 6, 2012.
   Google Scholar
• Anonymous. 2014. In brief: Testosterone and cardiovascular risk. Med Lett Drugs Ther 56: 17.
   Web of Science ®Google Scholar
• (The Practice Committee of the) American Society for Reproductive Medicine. 2008. Progesterone supplementation during the luteal phase and in early pregnancy in the treatment of infertility: An educational bulletin. Fertility and Sterility 89: 789–92.
   PubMed Web of Science ®Google Scholar
• Anderson, G.L., H.L. Judd, A.M. Kaunitz, D.H. Barad, S.A. Beresford, M. Pettinger, J. Liu, S.G. McNeeley, A.M. Lopez and Women's Health Initiative Investigators. 2003. Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures: The Women's Health Initiative randomized trial. Journal of the American Medical Association 290: 1739–48.
   PubMed Web of Science ®Google Scholar
• Anderson, G.L., R.T. Chlebowski, A.K. Aragaki, L.H. Kuller, J.E. Manson, M. Gass, E. Bluhme, S. Connelly, F.A. Hubbell, D. Lane, L. Martin, J. Ockene, T. Rohan, R. Schenken, and J. Wactawski-Wende. 2012. Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: Extended follow-up of the Women's Health Initiative randomised placebo-controlled trial. Lancet Oncology 13: 476–86.
   PubMed Web of Science ®Google Scholar
• Bengiano, G., F.M. Primiero, and M. Farris. 2004. Clinical profile of contraceptive progestins. European Journal of Contraception and Reproductive Health Care 9: 182–93.
   PubMed Web of Science ®Google Scholar
• Bhadoria, A., U. Kapil, N. Sareen, and P. Singh. 2013. Reproductive factors and breast cancer: A case-control study in tertiary hospital in North India. Indian J Cancer 50: 316–21.
   PubMed Web of Science ®Google Scholar
• Breast Cancer Prevention Institute. 2007. Reproductive breast cancer risks and breast lobule maturation. http://www.bcpinstitute.org/reproductive.htm#R1.
   Google Scholar
• Breast Cancer Prevention Institute. 2009. What's the connection?. Ft. Collins, CO: Life Cycle Books.
   Google Scholar
• Breast Cancer Prevention Institute. 2013a. Press release: Researchers find nearly 90% increase in advanced breast cancers in 33 years, but ignore elephants in living room – links to abortion and use of hormonal contraceptive steroids. http://www.abortionbreastcancer.com/press_releases/130304/index.htm.
   Google Scholar
• Breast Cancer Prevention Institute. 2013b. Epidemiological studies: Induced abortion and breast cancer risk. http://www.bcpinstitute.org/PDF/BCPI-FactSheet-Epidemiol-studies_11_2013.pdf.
   Google Scholar
• Brind, J. 2013a. Abortion breast cancer link explodes in Asia while West covers it up. http://www.lifenews.com/2013/08/15/abortion-breast-cancer-link-explodes-in-asia-while-west-covers-it-up/.
   Google Scholar
• Brind, J. 2013b. Abortion-breast cancer study not valid for assessing overall association. Acta obstetricia et gynecologica Scandinavica 92: 1427.
   PubMed Web of Science ®Google Scholar
• Brind, J., V.M. Chinchilli, W. Severs, and J. Summy-Long. 1996. Induced abortion as an independent risk factor for breast cancer: A comprehensive review and meta-analysis. Journal of Epidemiology and Community Health 50: 481–96.
   PubMed Web of Science ®Google Scholar
• Byrne, D. 2007. Why isn't this study on the pill heeded? Chicago Tribune. http://articles.chicagotribune.com/2007-12-03/news/0712020143_1_breast-cancer-premenopausal-women-pill.
   Google Scholar
• Campagnoli, C., F. Clavel-Chapelon, R. Kaaks, C. Peris, and F. Berrino. 2005. Progestins and progesterone in hormone replacement therapy and the risk of breast cancer. Journal of Steroid Biochemistry 96: 95–108.
   Google Scholar
• Carroll, P.S. 2007. The breast cancer epidemic: Modeling and prediction based on abortion and other risk factors. Journal of American Physicians and Surgeons 12: 72–8.
   Google Scholar
• Cerhan, J.R. 2006. Oral contraceptive use and breast cancer risk: Current status. Mayo Clinic Proceedings 81: 1287–9.
   PubMed Web of Science ®Google Scholar
• Chin-Quee, D.S., M. Wedderburn, C. Otterness, B. Janowitz, and M. Chen-Mok. 2010. Bridging emergency contraceptive pill users to regular contraception: Results from a randomized trial in Jamaica. Contraception 81: 133–9.
   PubMed Web of Science ®Google Scholar
• Chlebowski, R.T., S.L. Hendrix, R.D. Langer, M.L. Stefanick, M. Gass, D. Lane, R.J. Rodabough, M.A. Gilligan, M.G. Cyr, C.A. Thomson, J. Khandekar, H. Petrovitch, A. McTiernan and WHI Investigators. 2003. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: The Women's Health Initiative randomized trial. Journal of the American Medical Association 289: 3243–53.
   PubMed Web of Science ®Google Scholar
• Chlebowski, R.T., G.L. Anderson, M. Gass, D.S. Lane, A.K. Aragaki, L.H. Kuller, J.E. Manson, M.L. Stefanick, J. Ockene, G.E. Sarto, K.C. Johnson, J. Wactawski-Wende, P.M. Ravdin, R. Schenken, S.L. Hendrix, A. Rajkovic, T.E. Rohan, S. Yasmeen, R.L. Prentice and WHI Investigators. 2010. Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women. JAMA 304: 1684–92.
   PubMed Web of Science ®Google Scholar
• Cogliano, V., Y. Grosse, R. Baan, K. Straif, B. Secretan, and F. El Ghissassi and World Health Organization International Agency for Research on Cancer. 2005. Carcinogenicity of combined oestrogen-progestogen contraceptives and menopausal treatment. Lancet Oncology 6: 552–3.
   PubMed Web of Science ®Google Scholar
• Colditz, G.A., S.E. Hankinson, D.J. Hunter, W.C. Willett, J.E. Manson, M.J. Stampfer, C. Hennekens, B. Rosner, and F.E. Speizer. 1995. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. New England Journal of Medicine 332: 1589–93.
   PubMed Web of Science ®Google Scholar
• Collaborative Group on Hormonal Factors in Breast Cancer. 1996. Breast cancer and hormonal contraceptives: Collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies. Lancet 347: 1713–27.
   PubMed Web of Science ®Google Scholar
• Cowley, G., and K. Springen. 2002. The end of the age of estrogen? Newsweek, 37–45.
   Google Scholar
• Daling, J.R., K.E. Malone, L.F. Voigt, E. White, and N.S. Weiss. 1994. Risk of breast cancer among young women: Relationship to induced abortion. J Natl Cancer Inst 86: 1584–92.
   PubMedGoogle Scholar
• De Silva, M., U. Senarath, M. Gunatilake, and D. Lokuhetty. 2010. Prolonged breastfeeding reduces risk of breast cancer in Sri Lankan women: A case-control study. Cancer Epidemiology 34: 267–73.
   PubMed Web of Science ®Google Scholar
• Dolle, J.M., J.R. Daling, E. White, L.A. Brinton, D.R. Doody, P.L. Porter, and K.E. Malone. 2009. Risk factors for triple-negative breast cancer in women under the age of 45 years. Cancer Epidemiology Biomarkers, and Prevention 18: 1157–66.
   PubMed Web of Science ®Google Scholar
• Edgren, R.A. 1974. Progestogens as contraceptives. J Reprod Med 13: 79–81.
   PubMed Web of Science ®Google Scholar
• Edgren, R.A., R.C. Jones, and D.L. Peterson. 1967. A biological classification of progestational agents. Fertility and Sterility 18: 238–56.
   PubMed Web of Science ®Google Scholar
• Erkkola, R., and L. Britt-Marie. 2005. Role of progestins in contraception. Acta obstetricia et gynecologica Scandinavica 84: 207–16.
   PubMed Web of Science ®Google Scholar
• Ertelt, S. 2013. Study shows highest-ever abortion breast cancer risk for women. http://www.lifenews.com/2013/08/14/study-shows-highest-abortion-breast-cancer-risk-ever-for-women/.
   Google Scholar
• Farhat, G.N., R. Waller, D.S.M. Buist, T. Onega, and K. Kerlikowske. 2010. Changes in invasive breast cancer and ductal carcinoma in situ rates in relation to the decline in hormone therapy use. Journal of Clinical Oncology 28: 5140–6. http://jco.ascopubs.org/content/early/2010/11/08/JCO.2010.29.5121.
   PubMed Web of Science ®Google Scholar
• FDA News Release. 2013. U.S. Food and Drug Administration: FDA approves Plan B One-Step emergency contraceptive for use without a prescription for all women of child-bearing potential. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm358082.htm.
   Google Scholar
• Feeley, J. 2013. Pfizer to pay $1.8 million in prempro punitive damages. BloombergBusinessweek. http://www.businessweek.com/news/2013-08-07/pfizer-to-pay-1-dot-8-million-in-prempro-punitive-damages-1.
   Google Scholar
• Flesch-Janys, S.T., E. Mutchelknauss, S. Kropp, N. Obi, E. Vettorazzi, W. Braendle, G. Bastert, S. Hentschel, J. Berger, and J. Chang-Claude. 2008. Risk of different histological types of postmenopausal breast cancer by type and regimen of menopausal hormone therapy. International Journal of Cancer 123: 933–41.
   PubMed Web of Science ®Google Scholar
• Gambrell, R.D. Jr., F.M. Massey, T.A. Castaneda, A.J. Ugenas, C.A. Ricci, and J.M. Wright. 1980. Use of the progestogen challenge test to reduce the risk of endometrial cancer. Obstetrics and Gynecology 55: 732–8.
   PubMed Web of Science ®Google Scholar
• Gast Law Office, and William, E. 2013. What's it all about? An explanation of hormone therapy lawsuits. http://www.gastlawfirm.com/HRTmedication.htm.
   Google Scholar
• Giersig, C. 2002. Progestin and breast cancer: The missing pieces of the puzzle. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 51: 782–6. (Abstract in English).
   Google Scholar
• Grosse, Y., R. Baan, K. Straif, B. Secretan, F. El Ghissassi, V. Bouvard, L. Benbrahim-Tallee, N. Guha, L. Galichet, V. Cogliano and WHO International Agency for Research on Cancer Monograph Working Group. 2009. A review of human carcinogens-Part A: Pharmaceuticals. Lancet Oncology 10: 13–4.
   PubMed Web of Science ®Google Scholar
• Guttmacher Institute. 2013. Facts on induced abortion in the United States. http://www.guttmacher.org/pubs/fb_induced_abortion.pdf.
   Google Scholar
• Hajian-Tilaki, K.O., and T. Kaveh-Ahangar. 2011. Reproductive factors associated with breast cancer risk in northern Iran. Medical Oncology 28: 441–6.
   PubMed Web of Science ®Google Scholar
• Hays, J., J.K. Ockene, R.L. Brunner, J.M. Kotchen, J.E. Manson, R.E. Patterson, A.K. Aragaki, S.A. Shumaker, R.G. Brzyski, A.Z. LaCroix, I.A. Granek, B.G. Valanis and Women's Health Initiative Investigators. 2003. Effects of estrogen plus progestin on health-related quality of life. New England Journal of Medicine 348: 1839–54.
   PubMed Web of Science ®Google Scholar
• Heffron, R., D. Donnell, H. Rees, C. Celum, N. Mugo, E. Were, G. de Bruyn, E. Nakku-Joloba, K. Ngure, J. Kiarie, R.W. Coombs, J.M. Baeten and Partners in Prevention HSV/HIV Transmission Study Team. 2012. Use of hormonal contraceptives and risk of HIV-1 transmission: A prospective cohort study. Lancet Infectious Disease 12: 19–26.
   PubMed Web of Science ®Google Scholar
• Higano, R., W.N. Robinson, and W.D. Cohen. 1960. Effects of long-term administration of estrogens on serum lipids of postmenopausal women. New England Journal of Medincie 263: 828–31.
   PubMed Web of Science ®Google Scholar
• Huang, Y., X. Zhang, W. Li, F. Song, H. Dai, J. Wang, Y. Gao, X. Liu, C. Chen, Y. Yan, Y. Wang, and K. Chen. 2014. A meta-analysis of the association between induced abortion and breast cancer among Chinese females. Cancer Causes and Control 25: 227–36.
   PubMed Web of Science ®Google Scholar
• Hulley, S., D. Grady, T. Bush, C. Furberg, D. Herrington, B. Riggs, and E. Vittinghoff. 1998. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. Journal of the American Medical Association 280: 605–13.
   PubMed Web of Science ®Google Scholar
• Hunter, D.J., G.A. Colditz, S.E. Hankinson, S. Malspeis, D. Spiegelman, W. Chen, M.J. Stampfer, and W.C. Willett. 2010. Oral contraceptive use and breast cancer: A prospective study of young women. Cancer Epidemiology, Biomarkers and Preventions 19: 2496–502.
   PubMed Web of Science ®Google Scholar
• International Agency for Research on Cancer (IARC). 1999. IARC monographs on the evaluation of carcinogenic risks to humans. 1999. Vol 72; Hormonal contraception and post-menopausal hormonal therapy. Lyon, France: IARC.
   Google Scholar
• Jabeen, S., M. Haque, J. Islam, M.S. Hossain, A. Begum, and M.A. Kashem. 2013. Breast cancer and some epidemiological factors: A hospital based study. Journal of Dhaka Medical College 22: 61–6.
   Google Scholar
• Jiang, A.R., G. Chang-Ming, J.-H. Ding, S.-P. Li, Y-T. Liu, H-X. Coa, J.Z. Wu, J.H. Tang, Y. Qian, and K. Tajima. 2012. Abortions and breast cancer risk in premenopausal and postmenopausal women in Jiangsu province of China. Asian Pacific Journal of Cancer Prevention 13: 33–5.
   PubMedGoogle Scholar
• Johnson, R.H., F.L. Chien, and A. Bleyer. 2013. Incidence of breast cancer with distant involvement among women in the United States, 1976 to 2009. Journal of the American Medical Association 309: 800–5.
   PubMed Web of Science ®Google Scholar
• Kahlenborn, C., F. Modugno, D.M. Potter, and W.B. Severs. 2006. Oral contraceptive use as a risk factor for premenopausal breast cancer: A meta-analysis. Mayo Clinic Proceedings 81: 1290–302.
   PubMed Web of Science ®Google Scholar
• Kamath, R., K.S. Mahajan, L. Ashok, and T.S. Sanai. 2013. A study on risk factors of breast cancer among patients attending the tertiary care hospital in Udupi district. Indian Journal of Community Medicine 3: 895–9.
   Google Scholar
• (Susan G.) Komen for the cure. 2012. Risk factors and prevention: Factors that do not increase the breast cancer risk. http://ww5.komen.org/BreastCancer/LowerYourRisk.html#FactorsNotRelatedToRisk.
   Google Scholar
• Kumle, M., E. Weiderpass, T. Braaten, I. Persson, H.-O. Adami, and E. Lund. 2002. Use of oral contraceptives and breast cancer risk: The Norwegian-Swedish women's lifestyle and health cohort. Cancer Epidemiology, Biomarkers, and Prevention 11: 1375–81.
   PubMed Web of Science ®Google Scholar
• LaCroix, A.Z., R.T. Chlebowski, J.E. Manson, A.K. Aragaki, K.C. Johnson, L. Martin, K.L. Margolis, M.L. Stefanick, R. Brzyski, J.D. Curb, B.V. Howard, C.E. Lewis, J. Wactawski-Wende and WHI Investigators. 2011. Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: A randomized controlled trial. Journal of the American Medical Association 305: 1305–14.
   PubMed Web of Science ®Google Scholar
• Lanfranchi, A. 2008. The federal government and academic texts as barriers to informed consent. Journal of American Physicians and Surgeons 13: 12–5.
   Google Scholar
• Lanfranchi, A. 2009. Normal breast physiology: The reasons hormonal contraceptives and induced abortion increase breast-cancer risk. Linacre Quarterly 76: 236–49.
   Google Scholar
• Li, C.I., K.E. Malone, P.L. Porter, N.S. Weiss, M.T. Tang, K.L. Cushing-Haugen, and J.R. Daling. 2003. Relationship between long durations and different regimens of hormone therapy and risk of breast cancer. Journal of the American Medical Association 289: 3254–63.
   PubMed Web of Science ®Google Scholar
• Linos, E., D. Spanos, B.A. Rosner, K. Linos, T. Hesketh, J.D. Qu, Y.T. Gao, W. Zheng, and G.A. Colditz. 2008. Effects of reproductive and demographic changes on breast cancer incidence in China: A modeling analysis. Journal of National Cancer Institute 100: 1352–60.
   PubMedGoogle Scholar
• Lumachi, F., A.C. Frigo, U. Basso, V. Tombolan, and M. Ermani. 2010. Estrogen therapy and risk of breast cancer in postmenopausal women: A case-control study and results of a multivariate analysis. Menopause 17: 524–8.
   PubMed Web of Science ®Google Scholar
• MacMahon, B.1969. Epidemiologic aspects of cancer 1969. CA Cancer Journal for Clinicians 19: 27–35.
   PubMedGoogle Scholar
• MacMahon, B., P. Cole, T.M. Lin, C.R. Lowe, A.P. Mirra, B. Ravnihar, E.J. Salber, V.G. Valaoras, and S. Yuasa. 1970. Age at first birth and breast cancer risk. Bulletin of the World Health Organization 43: 209–21.
   PubMed Web of Science ®Google Scholar
• Mahouri, K., M. Dehghani Zahedani, and S. Zare. 2007. Breast cancer risk factors in south of Islamic Republic of Iran: A case-control study. Eastern Mediterranean Health Journal 13: 1265–73.
   PubMedGoogle Scholar
• Majumdar, S.R., E.A. Almasi, and R.S. Stafford. 2004. Promotion and Prescribing of hormone therapy after report of harm by the Women's Health Initiative. Journal of the American Medical Association 292:1983–88.
   PubMed Web of Science ®Google Scholar
• Manson, J.E., R.T. Chlebowski, M.L. Stefanick, A.K. Aragaki, J.E. Rossouw, R.L. Prentice, G. Anderson, B.V. Howard, C.A. Thomson, A.Z. LaCroix, J. Wactawski-Wende, R.D. Jackson, M. Limacher, K.L. Margolis, S. Wassertheil-Smoller, S.A. Beresford, J.A. Cauley, C.B. Eaton, M. Gass, J. Hsia, K.C. Johnson, C. Kooperberg, L.H. Kuller, C.E. Lewis, S. Liu, L.W. Martin, J.K. Ockene, M.J. O'Sullivan, L.H. Powell, M.S. Simon, L. Van Horn, M.Z. Vitolins, and R.B. Wallace. 2013. Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials. Journal of the American Medical Association 310: 1353–68.
   PubMed Web of Science ®Google Scholar
• Marchione, M. 2006. Breast cancer rates drop dramatically. WashingtonPost. December 14, 2006. http://www.washingtonpost.com/wp-dyn/content/article/2006/12/14/AR2006121400877.html.
   Google Scholar
• Meehan, M. 2013. New support group focuses on 35 and under: Young women feel isolated after diagnosis. Lexington Herald-Leader, A1.
   Google Scholar
• Motie, M.R., S. Besharat, R. Torkjazi, M. Shojaa, M. Besharat, A. Keshtkar, G. Roshandel, S. Besharat, and A.A. Fateme. 2011. Modifiable risk of breast cancer in northeast Iran: Hope for the future-a case-control study. Breast Care (Basel) 6: 453–6.
   PubMed Web of Science ®Google Scholar
• Nabel, E.G., 2013. The Women's Health Initiative—a victory for women. Journal of the American Medical Association 310: 1349–50.
   PubMed Web of Science ®Google Scholar
• National Cancer Institute. 2013. Breast cancer prevention: Factors associated with increased breast cancer risk. http://www.cancer.gov/cancertopics/pdq/prevention/breast/HealthProfessional #Section 175.
   Google Scholar
• Nelson, H.D., L.L. Humphrey, P. Nygren, S.M. Teutsch, and J.D. Allan. 2002. Postmenopausal hormone replacement therapy: Scientific review. Journal of the American Medical Association 288: 872–81.
   PubMed Web of Science ®Google Scholar
• Oettel, M., A. Komor, N.P. Goncharov, A. Kurischko, J. Streck, and K. Schubert. 1980. STS 557 an interceptive in rodents and baboons. Contraception 21: 537–45.
   PubMed Web of Science ®Google Scholar
• Ozmen, V., B. Ozcinar, H. Karanlik, N. Cabioglu, M. Tukenmez, R. Disci, T. Ozmen, A. Igci, M. Muslumanoglu, M. Kecer, and A. Soran. 2009. Breast cancer risk factors in Turkish women – a University Hospital based nested case control study. World Journal of Surgical Oncology 8: 7–37.
   Google Scholar
• Peck, R., and C.W. Norris. 2012. Significant risks of oral contraceptives (OCPs) included in preventive care mandate: Why this drug class should not be included in preventive care mandate. Linacre Quarterly 79: 41–56.
   PubMedGoogle Scholar
• Physicians' desk reference. 2005. 3358–3361. Montvale, NJ: Thomson PDR.
   Google Scholar
• Physicians' desk reference. 2004. 3455. Montvale, NJ: Thomson.
   Google Scholar
• Physicians' desk reference. 2005. 3366–3371. Montvale, NJ: Thomson.
   Google Scholar
• Pritts, E.A., and A.K. Atwood. 2002. Luteal phase support in infertility treatment: A meta-analysis of the randomized trials. Human Reproduction 17: 2287–99.
   PubMed Web of Science ®Google Scholar
• Rai, M., A. Pandey, M. Singh, A. Rai, and H.S. Shukia. 2008. Assessment of epidemiological factors associated with breast cancer. Indian Journal of Prevention Society of Medicine 39: 71–7.
   Google Scholar
• Raza, U., A. Khanam, Meh-Jabeen, M. Furqan, Saleem-ul-Haque. 2011. Risk profile for breast carcinoma and tumour histopathology of medical uninsured patients in Pakistan. J Ayub Medical College, Abbottabad 23: 9–14.
   PubMedGoogle Scholar
• Remennick, L.I. 1989. Reproductive patterns and cancer incidence in women: A population-based correlation study in the USSR. International Journal of Epidemiology 18: 498–510.
   PubMed Web of Science ®Google Scholar
• Reznik, S.E. 2010. ‘Plan B:’ How it works—Science shows it is not an abortifacient. Health Progress 91: 59–61.
   PubMedGoogle Scholar
• Rossouw, J.E., G.L. Anderson, R.L. Prentice, A.Z. LaCroix, C. Kooperberg, M.L. Stefanick, R.D. Jackson, S.A. Beresford, B.V. Howard, K.C. Johnson, J.M. Kotchen, J. Ockene , and Writing Group for the Women's Health Initiative Investigators. 2002. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative Randomized Controlled Trial. Journal of the American Medical Association 288: 321–33.
   PubMed Web of Science ®Google Scholar
• Rowland, M. 1965. Editorial. International Journal of Fertility 10: 97.
   Google Scholar
• Russo, J., and I.H. Russo. 1980. Susceptibility of the mammary gland to carcinogenesis. II. Pregnancy interruption as a risk factor in tumor incidence. American Journal of Pathology 100: 497–512.
   PubMed Web of Science ®Google Scholar
• Schlesselman, J.J. 1982. Case-control studies: Design, conduct, analysis. New York: Oxford University Press.
   Google Scholar
• Schneider, A.P. II 2007. Co-habitation: Ten facts. New Oxford Review 74: 36–7.
   Google Scholar
• Segi, M., I. Fukushima, S. Fujisaku, M. Kurihara, S. Saito, K. Asano, and M. Kamoi. 1957. An epidemiological study on cancer in Japan. GANN 48 (Suppl.):1–63.
   Google Scholar
• Shumaker, S.A., C. Legault, S.R. Rapp, L. Thal, R.B. Wallace, J.K. Ockene, S.L. Hendrix, Jones, B.N. 3rd, A.R. Assaf, R.D. Jackson, J.M. Kotchen, S. Wassertheil-Smoller, J. Wactawski-Wende , and WHIMS Investigators. 2003. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: The Women's Health Initiative Memory Study: A randomized controlled trial. Journal of the American Medical Association 289: 2651–2.
   PubMed Web of Science ®Google Scholar
• Siegel, R., J. Ma, Z. Zou, and A. Jemal. 2014. Cancer statistics, 2014. CA Cancer Journal of Clinicians 64: 9–29.
   PubMed Web of Science ®Google Scholar
• Silverberg, E., and R.N. Grant. 1970. Cancer statistics, 1970. CA Cancer Journal of Clinicians 23: 1–27.
   Google Scholar
• Silverberg, E., and A.I. Holleb. 1973. Cancer statistics, 1973. CA Cancer Journal of Clinicians 23: 2–27.
   Google Scholar
• Sitruk-Ware, R. 2006. New progestagens for contraceptive use. Human Reproduction Update 12: 169–78.
   PubMed Web of Science ®Google Scholar
• Stampfer, M.J., W.C. Willett, G.A. Colditz, B. Rosner, F.E. Speizer, and C.H. Hennekens. 1985. A prospective study of postmenopausal estrogen therapy and coronary heart disease. New England Journal of Medicine 313: 1044–9.
   PubMed Web of Science ®Google Scholar
• Stanczyk, F.Z., J.P. Hapgood, S. Winer, Mishell, D.R. Jr. 2013. Progestogens used in postmenopausal hormone therapy: Differences in their pharmacological properties, intracellular actions, and clinical effects. Endocrine Reviews 34: 171–208.
   PubMed Web of Science ®Google Scholar
• Stedman's medical dictionary. 28th ed. 2006. Philadelphia, PA: Lippincott, Williams & Wilkins Co.
   Google Scholar
• Sturdee, D.W. 2013. Are progestins really necessary as part of a combined HRT regimen? Climacteric 16 (Suppl. 1):79–84.
   PubMed Web of Science ®Google Scholar
• Szabi, L. 2013. Deadly breast cancers are rising in young women. USA Today. http://www.usatoday.com/story/news/nation/2013/02/26/breast-cancers-young-women/1949157/.
   Google Scholar
• Trichopoulos, D., C.C. Hsieh, B. MacMahon, T.M. Lin, C.R. Lowe, A.P. Mirra, B. Ravnihar, E.J. Salber, V.G. Valaoras, and S. Yuasa. 1983. Age at any birth and breast cancer risk. International Journal of Cancer 31: 701–4.
   PubMed Web of Science ®Google Scholar
• Trichopoulos, D., P. Cole, E.F. Cook, M. Feinleib, R. Hoover, C.C. Hsieh, D. Hunter, R. Monson, N. Mueller, M. Rahu, E. Rimm, K. Rothman, M. Stampfer, N. Weiss, W. Willett, and H.O. Adami. 2008. MacMahon (1923–2007): founder of modern epidemiology. Cancer Causes & Control 19: 329–37.
   PubMed Web of Science ®Google Scholar
• Trussell, J., E.B. Schwarz, and R.E. Gutherie. 2008. No such thing as an easy (or EC) fix. Contraception 78: 351–4.
   PubMed Web of Science ®Google Scholar
• US National Institute of Health: National Cancer Institute. 2013. Surveillance epidemiology and end results (SEER). http://seer.cancer.gov/statfacts/html/breast.html.
   Google Scholar
• Watson Laboratories, Inc. 2013. PDR.net. Progesterone. http://www.pdr.net/drug-summary/progesterone?druglabelid=2388.
   Google Scholar
• Webster's New World College Dictionary. 4th edition. 2002. Cleveland:Wiley Publishing, Inc.
   Google Scholar
• White, E., J.R. Daling, T.L. Norsted, and J. Chu. 1987. Rising incidence of breast cancer among young women in Washington State. Journal of National Cancer Institute 79: 239–43.
   PubMedGoogle Scholar
• Wilson, R.A. 1962. The roles of estrogen and progesterone in breast and genital cancer. Journal of the American Medical Association 182: 327–31.
   Web of Science ®Google Scholar
• Wilson, R.A. 1966. Feminine forever. New York: M. Evans and Co.
   Google Scholar
• World Health Organization International Agency for Research on Cancer (WHO-IARC). 2007. IARC monographs on the evaluation of carcinogenic risks to humans. Lyon, France: World Health Organization.
   Google Scholar
• Wu, C.Q., S.M. Grandi, K.B. Filion, H.A. Abenhaim, L. Joseph, and M.J. Eisenberg. 2013. Drospirenone-containing oral contraceptive pills and the risk of venous and arterial thrombosis: A systematic review. British Journal of Obstetrics and Gynaecology 120: 801–10.
   Google Scholar
• Wyeth Pharmaceuticals, Inc. 2013. Premarin tablets (conjugated estrogens). http://www.pdr.net/drug-summary/premarin-tablets?druglabelid=622.
   Google Scholar
• Xing, P., J. Li, and F. Jin. 2010. A case-control study of reproductive factors associated with subtypes of breast cancer in Northeast China. Medical Oncology 27: 926–31.
   PubMed Web of Science ®Google Scholar
• Yager, J.D., and N.E. Davidson. 2006. Mechanism of disease: Estrogen carcinogenesis in breast cancer. N England Journal of Medicine 354: 270–2.
   PubMed Web of Science ®Google Scholar
• Ye, Z., D.L. Gao, Q. Qin, R.M. Ray, and D.B. Thomas. 2002. Breast cancer in relation to induced abortions in a cohort of Chinese women. British Journal of Cancer 87: 977–81.
   PubMed Web of Science ®Google Scholar
• Ziel, H.K., and W.D. Finkle. 1975. Increased risk of endometrial carcinoma among users of conjugated estrogens. New England Journal of Medicine 293: 1167–70.
   PubMed Web of Science ®Google Scholar